Total Payments
$72,614
2024 Payments
$36,820
Companies
19
Transactions
201
Medicare Patients
1,248
Medicare Billing
$211,916
Payment Breakdown by Category
Other$51,123 (70.4%)
Consulting$8,600 (11.8%)
Food & Beverage$7,017 (9.7%)
Travel$5,756 (7.9%)
Education$118.69 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $51,123 | 23 | 70.4% |
| Consulting Fee | $8,600 | 4 | 11.8% |
| Food and Beverage | $7,017 | 157 | 9.7% |
| Travel and Lodging | $5,756 | 15 | 7.9% |
| Education | $118.69 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $52,936 | 92 | $0 (2024) |
| Janssen Biotech, Inc. | $13,075 | 25 | $0 (2024) |
| Gilead Sciences, Inc. | $2,600 | 2 | $0 (2019) |
| Amgen Inc. | $1,623 | 28 | $0 (2024) |
| GlaxoSmithKline, LLC. | $592.35 | 18 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $353.58 | 5 | $0 (2022) |
| Horizon Therapeutics plc | $345.64 | 5 | $0 (2021) |
| Aurinia Pharma U.S., Inc. | $221.39 | 4 | $0 (2024) |
| Horizon Pharma plc | $185.06 | 3 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $168.91 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $36,820 | 65 | ABBVIE INC. ($23,328) |
| 2023 | $29,791 | 67 | AbbVie Inc. ($28,976) |
| 2022 | $785.53 | 24 | ABBVIE INC. ($372.61) |
| 2021 | $631.36 | 7 | Amgen Inc. ($214.87) |
| 2020 | $449.45 | 8 | Amgen Inc. ($293.72) |
| 2019 | $3,391 | 19 | Gilead Sciences, Inc. ($2,600) |
| 2018 | $565.48 | 9 | Novartis Pharmaceuticals Corporation ($197.51) |
| 2017 | $180.44 | 2 | Janssen Biotech, Inc. ($99.00) |
All Payment Transactions
201 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $4.78 | General |
| Category: Immunology | ||||||
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.45 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $33.54 | General |
| Category: Bone Health | ||||||
| 12/10/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: Bone Health | ||||||
| 12/05/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $132.87 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,050.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/26/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), TREMFYA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,890.00 | General |
| Category: Immunology | ||||||
| 10/26/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), TREMFYA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,890.00 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), TREMFYA | Travel and Lodging | In-kind items and services | $922.61 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), TREMFYA | Food and Beverage | In-kind items and services | $38.52 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), TREMFYA | Travel and Lodging | In-kind items and services | $878.82 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), TREMFYA | Food and Beverage | In-kind items and services | $127.00 | General |
| Category: Immunology | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.06 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.40 | General |
| Category: IMMUNOLOGY | ||||||
| 08/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,575.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/12/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $54.35 | General |
| Category: Bone Health | ||||||
| 07/29/2024 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: Immunology | ||||||
| 07/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.69 | General |
| Category: IMMUNOLOGY | ||||||
| 07/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $103.41 | General |
| Category: IMMUNOLOGY | ||||||
| 07/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.10 | General |
| Category: IMMUNOLOGY | ||||||
| 07/03/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: IMMUNOLOGY | ||||||
| 07/02/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $6.07 | General |
| Category: IMMUNOLOGY | ||||||
| 06/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,837.50 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 259 | 1,638 | $108,536 | $51,885 |
| 2022 | 7 | 307 | 1,617 | $125,612 | $56,631 |
| 2021 | 10 | 374 | 1,670 | $144,933 | $61,856 |
| 2020 | 10 | 308 | 1,327 | $110,596 | $41,544 |
Total Patients
1,248
Total Services
6,252
Medicare Billing
$211,916
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 14 | 1,320 | $33,000 | $23,885 | 72.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 141 | 204 | $45,288 | $17,067 | 37.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 40 | 40 | $13,840 | $4,695 | 33.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 29 | $8,700 | $3,625 | 41.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $4,620 | $1,712 | 37.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 11 | $1,639 | $682.78 | 41.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 15 | 23 | $1,449 | $219.00 | 15.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 179 | 278 | $61,716 | $24,975 | 40.5% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 13 | 1,200 | $30,000 | $20,415 | 68.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 59 | 59 | $20,414 | $6,387 | 31.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 15 | 15 | $6,300 | $2,314 | 36.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 11 | $3,300 | $1,431 | 43.4% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2022 | 16 | 32 | $2,496 | $891.49 | 35.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 22 | $1,386 | $216.00 | 15.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 146 | 251 | $55,722 | $22,772 | 40.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 14 | 1,140 | $28,500 | $17,976 | 63.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 69 | 69 | $23,874 | $8,403 | 35.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 31 | 31 | $13,020 | $5,079 | 39.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 16 | 19 | $5,700 | $2,211 | 38.8% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2021 | 35 | 68 | $5,304 | $1,912 | 36.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 19 | 20 | $2,980 | $1,305 | 43.8% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 12 | 18 | $5,936 | $1,137 | 19.2% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2021 | 17 | 33 | $2,574 | $858.24 | 33.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 15 | 21 | $1,323 | $203.25 | 15.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 125 | 203 | $44,764 | $14,766 | 33.0% |
About Devon Charlton
Devon Charlton is a Rheumatology healthcare provider based in New Castle, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/02/2012. The National Provider Identifier (NPI) number assigned to this provider is 1215203443.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Devon Charlton has received a total of $72,614 in payments from pharmaceutical and medical device companies, with $36,820 received in 2024. These payments were reported across 201 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($51,123).
As a Medicare-enrolled provider, Charlton has provided services to 1,248 Medicare beneficiaries, totaling 6,252 services with total Medicare billing of $211,916. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location New Castle, PA
- Active Since 04/02/2012
- Last Updated 03/25/2021
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1215203443
Products in Payments
- RINVOQ (Biological) $38,501
- SKYRIZI (Biological) $12,346
- SIMPONI ARIA (Biological) $8,618
- TREMFYA (Drug) $4,327
- EVENITY (Biological) $680.43
- BENLYSTA (Biological) $592.35
- Enbrel (Biological) $445.55
- COSENTYX (Biological) $353.58
- KRYSTEXXA (Biological) $345.64
- LUPKYNIS (Drug) $221.39
- KRYSTEXXA (Drug) $185.06
- SAPHNELO (Biological) $168.91
- Prolia (Biological) $123.35
- Arcalyst (Drug) $108.12
- SIMPONI (Biological) $102.16
- REMICADE (Biological) $99.00
- Actemra (Biological) $92.36
- RINVOQ (Drug) $88.67
- XELJANZ (Drug) $81.44
- KEVZARA (Biological) $58.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.